Reportstack

Chong Kun Dang Pharmaceutical Corp. - Product Pipeline Review - 2012 New Report

 
Repost This

Naperville, IL -- (SBWIRE) -- 09/24/2012 -- CHONG KUN DANG PHARMACEUTICAL CORP. - Product Pipeline Review - 2012 provides data on the CHONG KUN DANG PHARMACEUTICAL CORP.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- CHONG KUN DANG PHARMACEUTICAL CORP. - Brief CHONG KUN DANG PHARMACEUTICAL CORP. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of CHONG KUN DANG PHARMACEUTICAL CORP. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of CHONG KUN DANG PHARMACEUTICAL CORP. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the CHONG KUN DANG PHARMACEUTICAL CORP.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate CHONG KUN DANG PHARMACEUTICAL CORP.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of CHONG KUN DANG PHARMACEUTICAL CORP. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the CHONG KUN DANG PHARMACEUTICAL CORP.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with CHONG KUN DANG PHARMACEUTICAL CORP..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of CHONG KUN DANG PHARMACEUTICAL CORP. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of CHONG KUN DANG PHARMACEUTICAL CORP.; CHONG KUN DANG PHARMACEUTICAL CORP. - Key Therapeutics; CHONG KUN DANG PHARMACEUTICAL CORP. - Pipeline Overview and Promising Molecules; CHONG KUN DANG PHARMACEUTICAL CORP. - News; CHONG KUN DANG PHARMACEUTICAL CORP. - Latest Updates; CHONG KUN DANG PHARMACEUTICAL CORP. - Pipeline; CHONG KUN DANG PHARMACEUTICAL CORP. - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/89964/chong-kun-dang-pharmaceutical-corp-product-pipeline-review-2012.html